Sort
8,912 grants matching “sars cov 2”
Small RNA-mediated warfare between viruses and their hosts
$194,250Paulina Pawlica · Icahn School Of Medicine At Mount Sinai · R35 · FY2023 · GM
Integrated Cognitive Rehabilitation and Cognitive Behavioral Therapy Intervention for patients with Post-COVID-19 Cognitive Impairment and Depression
$194,157Jacqueline Helcer Becker · Icahn School Of Medicine At Mount Sinai · K23 · FY2025 · MH
Non-Invasive Detection and Staging of Decubitus and Diabetic Ulcers
$194,150Jesse Vincent Jokerst · University Of California, San Diego · R21 · FY2020 · AG
Molecular Biology of Viral Diseases
$194,049Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · T32 · FY2012 · AI
Cellular and Molecular Consequences of SARS-CoV2 Infection in Pulmonary Vascular Endothelium
$194,017Jason Elinoff · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ART
$194,012Shahin Lockman · Brigham And Women'S Hospital · K24 · FY2022 · AI
4/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes (Administrative Supplement)
$193,936Charles Alexander Nelson · Boston Children'S Hospital · R34 · FY2021 · DA
IMPACT OF COVID-19 EXPOSURE ON U.S. BIRTH OUTCOMES
$193,911Jenna E. Nobles · University Of Wisconsin-Madison · R21 · FY2022 · HD
Mentoring in Community-engaged Research to Promote Health Equity for Latinos
$193,908Kathleen R Page · Johns Hopkins University · K24 · FY2023 · NR
Mentoring in Community-engaged Research to Promote Health Equity for Latinos
$193,908Kathleen R Page · Johns Hopkins University · K24 · FY2024 · NR
Innate Control of Adaptive Immunity to SARS-CoV-2
$193,860Benjamin Goldman-Israelow · Yale University · K08 · FY2025 · AI
Innate Control of Adaptive Immunity to SARS-CoV-2
$193,828Benjamin Goldman-Israelow · Yale University · K08 · FY2024 · AI
Optogenetic stimulation of TMEM16F to control phospholipid flip-flop
$193,765Huanghe Yang · Duke University · R21 · FY2022 · GM
Innate Control of Adaptive Immunity to SARS-CoV-2
$193,764Benjamin Goldman-Israelow · Yale University · K08 · FY2023 · AI
Establishment of a Transgenic Mouse Model for Middle East Respiratory Syndrome Co
$193,750Chien-Te K Tseng · University Of Texas Med Br Galveston · R21 · FY2015 · AI
Bi-substrate Inhibitors of SARS-CoV-2 Nsp14 Methyltransferase
$193,750Liqiang Chen · University Of Minnesota · R21 · FY2022 · AI
Viral Vectored COVID-19 Vaccines in a Guinea Pig Perinatal Infection Model
$193,750Mark R. Schleiss · University Of Minnesota · R21 · FY2022 · AI
Characterization the disruption of mitochondrial function and induction of oxidative stress by SARS-CoV2
$193,750Yidong Bai · University Of Texas Hlth Science Center · R21 · FY2022 · AI
The impact of aging and thymus regeneration on tissue-resident CD8 T cell responses to viral lung infection and vaccination
$193,750Ann Venables Griffith · University Of Texas Hlth Science Center · R21 · FY2023 · AI
Animal models of SARS-CoV-2 bacterial Coinfection
$193,750Yan Xiang · University Of Texas Hlth Science Center · R21 · FY2023 · AI
Roles of CCR10 in regulation of IgA responses to SARS-CoV-2 infection
$193,750Na Xiong · University Of Texas Hlth Science Center · R21 · FY2023 · AI
Innate Control of Adaptive Immunity to SARS-CoV-2
$193,716Benjamin Goldman-Israelow · Yale University · K08 · FY2021 · AI
Structural Basis for T Cell Recognition of SARS-CoV-2
$193,671Roy A Mariuzza · Univ Of Maryland, College Park · R21 · FY2024 · AI
Elucidating the impact of immune imprinting on SARS-CoV-2 variant vaccination strategies using a humanized mouse model
$193,644Anthony Bowen · Columbia University Health Sciences · K08 · FY2025 · AI
Elucidating the impact of immune imprinting on SARS-CoV-2 variant vaccination strategies using a humanized mouse model
$193,644Anthony Bowen · Columbia University Health Sciences · K08 · FY2024 · AI